Skip to main content
SpringerLink
Log in

Adverse Effects of Retinoids

  • Review Article
  • Adverse Drug Experience Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

Oral retinoids, synthetic derivatives of vitamin A, have been used in the treatment of various dermatoses over the last decade. The most useful drugs have been isotretinoin (13- cisretinoic acid) for nodulocystic acne and etretinate for psoriasis vulgaris. Retinoids are also effective in the treatment of papulosquamous dermatoses other than psoriasis (i.e. inherited disorders of keratinisation), cutaneous T-cell lymphoma and in chemotherapy and chemoprevention of cancer. However, systemic administration of these compounds is frequently associated with mucocutaneous side effects, liver toxicity and abnormalities of serum lipid profiles, which might be related to an increased risk of coronary heart disease. Of particular concern is the teratogenic effect of all retinoids, which limits their use in women of child-bearing potential Chronic toxicities from long term therapy with retinoids may result in skeletal abnormalities, usually mimicking diffuse idiopathic hyperostosis syndrome. Futhermore, the chronic use of retinoids in children may inhibit their growth due to premature epiphyseal closure. In contrast to other side effects of retinoids which are dose dependent and reversible upon withdrawal of the drug, it seems unlikely that bone abnormalities will resolve after discontinuation of the medication.

In view of the wide spectrum of toxicities, treatment with retinoids requires appropriate selection of patients, careful consideration of the benefit to risk ratio for each individual, periodic monitoring of clinical response and laboratory tests.

Clinicians should use special management techniques in order to prevent or minimise slide effects. Extensive investigations are currently being conducted in an attempt to develop new retinoids which will improve the therapeutic efficacy and reduce unwanted reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Archer CB, Cerio R, Griffiths WAD. Etretinate and acquired kinking of the hair. British Journal of Dermatology 12: 239, 1987

    Google Scholar 

  • Benke PJ. The isotretinoin teratogen syndrome. Journal of the American Medical Association 251: 3267–3269, 1984

    PubMed  CAS  Google Scholar 

  • Bershad G, Rubinstein A, Patterniti JR, et al. changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. New England Journal of Medicine 313: 981–985, 1985

    PubMed  CAS  Google Scholar 

  • Bluckman HS, Peck GL, Olsen TG, et al. Blepharoconjunctivitis; a side effect of 13-cis retinoic acid therapy for dermatologic disease. Ophthalmology 86: 753–758, 1979

    Google Scholar 

  • Boer J, Smeenk G. Nodular prurigo-like eruption induced by etretinate. British Journal of Dermatology 116: 271–274, 1987

    PubMed  CAS  Google Scholar 

  • Bollag W. Arotinoids: a new class of retinoid with activities in oncology and dermatology. Cancer Chemotherapy and Pharmacology 7: 27–29, 1981

    PubMed  CAS  Google Scholar 

  • Bollag W. The development of retinoids in experimental and clinical oncology and dermatology. Journal of the American Academy of Dermatology 9: 797–805, 1983

    PubMed  CAS  Google Scholar 

  • Bollag W. New retinoids with potential use in humans. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 274–288, Karger, Basel, 1985

    Google Scholar 

  • Brazzel RK, Colburn WA. Pharmacokinetics of the retinoids isotretinoin and etretinate: a comparative review. Journal of the American Academy of Dermatology 6: 642–651, 1982

    Google Scholar 

  • Brazzel RK, Vaue FM. Pharmacokinetics of isotretinoin during repetitive dosing to patients. European Journal of Clinical Pharmacology 24: 695–702, 1983

    Google Scholar 

  • Brun P, Baran R. Neonatal ichthyosis treated for seven years with etretinate without effects on growth or ossification: a case report. Current Therapeutic Research 40: 657–663, 1986

    Google Scholar 

  • Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 33: 484–486, 1984

    PubMed  CAS  Google Scholar 

  • Burge S, Ryan T. Diffuse hyperostosis associated with etretinate. Lancet 2: 397–398, 1985

    PubMed  CAS  Google Scholar 

  • Camuto P, Shupach J, Orbuch P, et al. Long term effects of etretinate on the liver in psoriasis. American Journal of Surgical Pathology 11: 30–37, 1987

    PubMed  CAS  Google Scholar 

  • Chen DT. Human pregnancy experience with the retinoids. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 398–406, Karger, Basel, 1985

    Google Scholar 

  • Chen D, Rofsky HE. Elevated CPK and isotretinoin. Journal of the American Academy of Dermatology 12: 582–583, 1985

    Google Scholar 

  • Collins MRL, James WD, Rodman VG. Etretinate photosensitivity. Journal of the American Academy of Dermatology 14: 274, 1986

    PubMed  CAS  Google Scholar 

  • Crivellato E. A rosacea-like eruption induced by Tigason RO 19-935g treatment. Acta Dermato-Venereologica 62: 450–452, 1982

    PubMed  CAS  Google Scholar 

  • David M, Borok M, Lowe NJ. Chronic efficacy and toxicity of acitretin in psoriasis. Clinical Research 36: 248A, 1988

    Google Scholar 

  • David M, Ginzburg A, Hodak G, et al. Palmoplantar eruption associated with etretinate therapy. Acta Dermato-Venereologica 66: 87–89, 1986

    PubMed  CAS  Google Scholar 

  • David M, Hodak E, Sandbank M, Gadoth N. Electromyographic abnormalities in patients under long term therapy with etretinate. Journal of the American Academy of Dermatology, in press, 1988

  • Dicken CH. Retinoids, a review. Journal of the American Academy of Dermatology 11: 541–552, 1984

    PubMed  CAS  Google Scholar 

  • Dicken CH, Connoly SM. Eruptive xanthoma associated with isotretinoin. Archives of Dermatology 116: 951–052, 1980

    PubMed  CAS  Google Scholar 

  • Diffey BL, Spiro JG, Hindson TC. Photosensitivity studies and isotretinoin therapy. Journal of the American Academy of Dermatology 12: 119;-120, 1985

    PubMed  CAS  Google Scholar 

  • DiGiovanna JJ, Helfgott R, Gerber GL, et al. Extraspinal tendon and ligament calcification after long term isotretinoin therapy. (Abstract.) Journal of Investigative Dermatology 88: 485, 1987

    Google Scholar 

  • DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. New England Journal of Medicine 315: 1177–1182, 1986

    PubMed  CAS  Google Scholar 

  • DiGiovanna JJ, Peck GL. Oral synthetic retinoid treatment in children. Pediatric Dermatology 1177–1188, 1983

  • DiGiovanna JJ, Peck GL. Retinoid toxicity. Progress in Dermatology 21: 1–8, 1987

    Google Scholar 

  • Dubertret L, Lebreton C, Touraine C, Touraine R. Inhibition of neutrophil migration by etretinate and its main metabolites. British Journal of Dermatology 107: 681–685, 1982

    PubMed  CAS  Google Scholar 

  • Elias PM, Williams ML. Retinoids, cancer and the skin. Archives of Dermatology 117: 160–180, 1981

    PubMed  CAS  Google Scholar 

  • Ellis CN, Gilbert M, Cohen KA et al. Increased muscle tone during etretinate therapy. Journal of the American Academy of Dermatology 14: 907–909, 1986

    PubMed  CAS  Google Scholar 

  • Ellis CN, Madison KC, Pennes DR, et al. Isotretinoin therapy is associated with early skeletal radiographie changes. Journal of the American Academy of Dermatology 10: 1024–1029, 1984

    PubMed  CAS  Google Scholar 

  • Ellis CN, Pennes DR, Madison KC, et al. Skeletal radiographie changes during retinoid therapy. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 440–444, Karger, Basel, 1985

    Google Scholar 

  • Ellis CN, Swanson NA, Grekin RC, et al. Etretinate therapy causes increases in lipid levels in patients with psoriasis. Archives of Dermatology 8: 559–562, 1982

    Google Scholar 

  • Ellis CN, Voorhees JJ. Etretinate therapy. Journal of the American Academy of Dermatology 16: 267–291, 1987

    PubMed  CAS  Google Scholar 

  • Exner JH, Dahod S, Pochi PE. Pyogenic granuloma like acne lesions during isotretinoin therapy. Archives of Dermatology 119: 808–811, 1983

    PubMed  CAS  Google Scholar 

  • Ferguso MM, Simpson NB, Hammersley N. Severe nail dystrophy associated with retinoid therapy. Lancet 2: 974, 1983

    Google Scholar 

  • Ferguson J, Johnson BE. Photosensitivity due to retinoids: clinical and laboratories studies. British Journal of Dermatology 115: 275–283, 1986

    PubMed  CAS  Google Scholar 

  • Foged EK, Jacobson FK. Side effects due to Ro-9359 (Tigason): a retrospective study. Dermatologica 164: 395–403, 1982

    PubMed  CAS  Google Scholar 

  • Fontan B, Bonafe JL, Moatti JP. Toxic effect of the aromatic retinoid etretinate. Archives of Dermatology 119: 187–188, 1983

    PubMed  CAS  Google Scholar 

  • Fraunfelder FT, Labraico JM, Meyer M. Adverse ocular reactions possibly associated with isotretinoin. American Journal of Ophthalmology 100: 534–537, 1985

    PubMed  CAS  Google Scholar 

  • Geelen JAG. Hypervitaminosis A induced teratogenesis. CRC Review of Toxicology 6: 351–375, 1979

    CAS  Google Scholar 

  • Geiger JM, Ott F, Bollag W. Clinical evaluation of an aromatic retinoid Ro 10-1670 in severe psoriasis. Current Therapeutic Research 35: 735–740, 1984

    Google Scholar 

  • Gerber LH, Helfgott RK, Gross GG, et al. Vertebral abnormalities associated with synthetic retinoid use. Journal of the American Academy of Dermatology 10: 817–823, 1984

    PubMed  CAS  Google Scholar 

  • Gilbert M, Ellis CN, Voorhees JJ. Lack of skeletal radiographic changes during short-term etretinate therapy for psoriasis. Dermatologica 192: 160–163, 1986

    Google Scholar 

  • Glover MT, Peters AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. British Journal of Dermatology 116: 609–614, 1987

    PubMed  CAS  Google Scholar 

  • Goldstein JA, Socha-Szott A, Thomsen RS, et al. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. Journal of the American Academy of Dermatology 6: 760–765, 1982

    PubMed  CAS  Google Scholar 

  • Gollnick H, Schwartzkopf W, Proschle W, et al. Retinoids and blood lipids; an update and review. In Saurat (Ed.) Retinoids: new trends in research and therapy, p. 445, Karger, Basel, 1985

    Google Scholar 

  • Graham ML, Corey R, Califf R, et al. Isotretinoin and staphylococcus aureus infection. Archives of Dermatology 122: 815–817, 1986

    PubMed  Google Scholar 

  • Grattan CEH, Brown RD, Cowan MA, et al. Retinoids and eye-reduced function with isotretinoin. British Journal of Dermatology 117 (Suppl. 32): 23, 1987

    Google Scholar 

  • Gross E, Helfgott R, Hicks J, et al. Evaluation of vertebral spine osteoporosis in patients treated with isotretinoin. Clinical Research 33: 642, 1985

    Google Scholar 

  • Halker-Sorenson L. Menstrual changes in a patient treated with etretinate. Lancet 2: 636, 1987

    Google Scholar 

  • Halker-Sorenson L. Sexual dysfunction in a patient treated with etretinate. Acta Dermato-Venereologica 68: 90, 1988

    Google Scholar 

  • Hanni R. Pharmacokinetic and metabolic pathway of systemi-cally applied retinoids. Dermatologica (Suppl.) 157: 5–10, 1978

    PubMed  Google Scholar 

  • Harrison PV. Retinoids and malignancy. Lancet 2: 801, 1987

    PubMed  CAS  Google Scholar 

  • Hays SB, Camisa C. Acquired pili torti in two patients treated with synthetic retinoids. Cutis 25: 466–468, 1985

    Google Scholar 

  • Hazen PG, Carney JF, Walker AE, et al. Depression — a side effect of 13-cis-retinoic acid therapy. Journal of the American Academy of Dermatology 9: 278–279, 1983

    PubMed  CAS  Google Scholar 

  • Helfman RJ, Brickman M, Fahey J. Isotretinoin dermatitis simulating acute pityriasis rosea. Cutis 33: 297–300, 1984

    PubMed  CAS  Google Scholar 

  • Hersh JH, Danhauer DS, Hand ME, et al. Retinoic acid embryopathy: timing of exposure and effects on fetal development. Journal of the American Medical Association 254: 909–910, 1985

    PubMed  CAS  Google Scholar 

  • Hodak E, David M, Feuerman EJ. Excessive granulation tissue during etretinate therapy. Journal of the American Academy of Dermatology 11: 1166–1167, 1984

    PubMed  CAS  Google Scholar 

  • Hodak E, Gadoth N, David M, Sandbank M. Muscle damage induced by isotretinoin. British Medical Journal 293: 425–426, 1986

    PubMed  CAS  Google Scholar 

  • Hodak E, David M, Gadoth N, Sandbank M. Etretinate-induced muscle damage. British Journal of Dermatology 116: 623–626, 1987

    PubMed  CAS  Google Scholar 

  • Hoffman La Roche. Tegison information brochure, Hoffman La Roche Inc, Nutley, 1987

    Google Scholar 

  • Jacyk WK. Elevated creatine phosphokinase levels associated with the use of etretinate. Journal of the American Academy of Dermatology 15: 710, 1986

    PubMed  CAS  Google Scholar 

  • James WD. Staphylococcus aureus and etretinate. Archives of Dermatology 122: 976–977, 1986

    PubMed  CAS  Google Scholar 

  • Johnston TM, Rapini RP. Isotretinoin-induced thrombocytopenia 17: 838–839, 1987

    Google Scholar 

  • Juhlin L. Ear ache during etretinate treatment. Acta Dermato-Venereologica 631: 182, 1983

    Google Scholar 

  • Kaiser-Kupfer MI, Peck GL, Carusa RL, et al. Abnormal retinal function associated with fenretinide: a synthetic retinoid. Archives of Ophthalmology 104: 69–70, 1986

    PubMed  CAS  Google Scholar 

  • Kamm JJ, Ashenfelter KO, Ehmann CW. Preclinical and clinical toxicology of selected retinoids. In Sporn et al. (Eds) The retinoids, Vol. 2, pp. 287–326, Academic Press, Orlando, 1984

    Google Scholar 

  • Kerr IG, Lippman ME, Jenkin J. Pharmacology of 13-cis-retinoic acid in humans. Cancer Research 42: 2069–2073, 1982

    PubMed  CAS  Google Scholar 

  • Kilcoyne RF, Cope R, Cunningham W, et al. Minimal spinal hyperostosis with low-dose isotretinoin therapy. Investigative Radiology 21: 41–44, 1986

    PubMed  CAS  Google Scholar 

  • Kingston TP, Lowe NJ, Winston J, et al. Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis. Clinics in Experimental Dermatology 11: 624–627, 1986

    CAS  Google Scholar 

  • Kingston TP, Matt L, Lowe NJ. Etretin therapy for severe psoriasis. Archives of Dermatology 123: 55–58, 1987

    PubMed  CAS  Google Scholar 

  • Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aorticopulmonary separation. Science 220: 1059–1061, 1983

    PubMed  CAS  Google Scholar 

  • Kramer M. Excessive cerumen production due to the aromatic retinoid Tigason, in a patient with Darier’s disease. Acta Dermato-Venereologica 62: 267–268, 1982

    PubMed  CAS  Google Scholar 

  • Laker MF, Green C, Bhuiyan AKMJ, et al. Isotretinoin and serum lipids: studies on fatty acid, apoprotein and intermediary metabolism. British Journal of Dermatology 117: 203–206, 1987

    PubMed  CAS  Google Scholar 

  • Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. New England Journal of Medicine 313: 837–841, 1985

    PubMed  CAS  Google Scholar 

  • Lambert W, De Bersaques J, Lefevre M, Cathior H, Leenheer A. Human serum level of the arotinoid RO 13-6298 by GC-MC. In Saurat (Ed.) Retinoids: new trends in research and therapy, Karger, Basel, 1985

    Google Scholar 

  • Lassus A. Systemic treatment of psoriasis with an oral retinoid acid derivative (RO 10-9359). British Journal of Dermatology 102: 195–202, 1980

    PubMed  CAS  Google Scholar 

  • Lassus A, Geiger JM, Nyblom, et al. Treatment of severe psoriasis with etretin (RO 10-1670). British Journal of Dermatology 117: 333–341, 1987

    PubMed  CAS  Google Scholar 

  • Lauharanta J. Oedema: a rare adverse reaction to etretinate. Correspondence. British Journal of Dermatology 106: 251, 1982

    Google Scholar 

  • Lauharanta J, Kapyaho K, Kanerva L. Effect of retinoids on the fructolytic activity of human spermatozoa. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 411–414, arger, Basel, 1985

    Google Scholar 

  • Levin J, Almeyda J. Erythroderma due to etretinate. British Journal of Dermatology 112: 373–374, 1985

    PubMed  CAS  Google Scholar 

  • Lindemayer H. Isotretinoin intoxication in attempted suicide. Acta Dermato-Venereologica 66: 452–453, 1986

    Google Scholar 

  • Lowe N, Ashley J, Borok M, et al. Fish oil supplementation causes decreases in serum triglyceride levels. Archives of Dermatology, in press, 1988

  • Lyons F, Laker MF, Marsden JR, et al. Effect of oral 13-cis-retinoic acid on serum lipids. British Journal of Dermatology 107: 591, 1982

    PubMed  CAS  Google Scholar 

  • Marsden JR, Laker MF, Shuster S. Biochemical effects of isotretinoin. In Saurat (Ed.) Retinoids: new trends in research and therapy, p. 461, Karger, Basel, 1985

    Google Scholar 

  • Marsden J. Hyperlipidemia due to isotretinoin and etretinate: possible mechanisms and consequences. British Journal of Dermatology 114: 401–402, 1986

    PubMed  CAS  Google Scholar 

  • Marsden JR. Effect of dietary fish oil on hyperlipidemia due to isotretinoin and etretinate. Human Toxicology 6: 219–222, 1987

    PubMed  CAS  Google Scholar 

  • Massarella J, Vance F, Bugge C. Etretinate kinetics during chronic dosing in severe psoriasis. Clinics in Pharmacology and Therapeutics 37: 439–446, 1985

    CAS  Google Scholar 

  • McBurney EI, Rosen DA. Elevated creatine phosphokinase with isotretinoin. Journal of the American Academy of Dermatology 10: 528–529, 1983

    Google Scholar 

  • McGuire J, Milstone L, Lawston J. Isotretinoin administration alters juvenile and adult bone. In Saurat (Ed.) Retinoid: new trends in research and therapy, pp. 419–439, Karger, Basel, 1985

    Google Scholar 

  • Melnick B, Gluck S, Jurigblut RM, Goerz G. Retrospective radiographic study of skeletal changes after long-term etretinate therapy. British Journal of Dermatology 116: 207, 1987

    Google Scholar 

  • Merot Y, Camenzind M, Geisen J, Saurat JH. Arotinoid ethyl ester (RO 13-6298): a long term pilot study in various dermatoses. Acta Dermato-Venereologica 67: 237–242, 1987

    PubMed  CAS  Google Scholar 

  • Milson J, Jones PH, King K, et al. Ophthalmological effects of 13-cis-retinoic acid therapy for acne vulgaris. British Journal of Dermatology 107: 491, 1981

    Google Scholar 

  • Milstone LM, McGuire J, Aslow RC. Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. Journal of the American Academy of Dermatology 7: 663–666, 1982

    PubMed  CAS  Google Scholar 

  • Molin L, Thomsen K, Wolden G, Lange Wantzin G. Retinoid dermatitis mimicking progression in mycosis fungoides: a report from Scandinavian mycosis fungoides group. Acta Dermato-Venereologica 65: 69–71, 1985

    PubMed  CAS  Google Scholar 

  • Orme M, Back DJ, Shaw MH, et al. Isotretinoin and contraception. Lancet 2: 752–753 1984

    PubMed  CAS  Google Scholar 

  • Orfanos CE. Retinoids and psoriasis. Acta Dermato-Venereologica (Suppl.) 112: 37–41, 1984

    PubMed  CAS  Google Scholar 

  • Palastine AG. Transient acute myopia resulting from isotretinoin (Accutane) therapy. American Ophthalmology 16: 660–662, 1984

    Google Scholar 

  • Paravicini U, Busslinger A. Etretinate and isotretinoin, two retinoids with different pharmacokinetic profiles. In Cunliffe & Miller (Eds) Retinoid therapy, pp. 11–23, MTP Press, Lancaster, 1984

    Google Scholar 

  • Patel IH, Koo KC, Olejnik N, Colburn WA. Comparative pharmacokinetics of isotretinoin and its metabolite 4-oxo-isotretinoin in dogs. Drug Metabolism and Disposition 10: 284–285, 1982

    PubMed  CAS  Google Scholar 

  • Pittsley RA, Yoder FW. Retinoid hyperostosis skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory ichthyosis. New England Journal of Medicine 308: 1012–1014, 1983

    PubMed  CAS  Google Scholar 

  • Prendiville J, Bingham EA, Burrows D. Premature epiphyseal closure — a complication of etretinate therapy in children. Journal of the American Academy of Dermatology 15: 1259–1262, 1986

    PubMed  CAS  Google Scholar 

  • Rismondov V, Ubels JL. Isotretinoin in lacrimal gland fluid and tears. Archives of Ophthalmology 105: 416–420, 1987

    Google Scholar 

  • Roenigk Jr HH. Retinoids: effect on the liver. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 476–488, Karger, Basel, 1985

    Google Scholar 

  • Rollman V, Vahlquist A. Oral isotretinoin (13-cis retinoic acid) therapy in acne: drug and vitamin A concentrations in serum and skin. Journal of Investigative Dermatology 86: 384–389, 1986

    PubMed  CAS  Google Scholar 

  • Rosa FW, Wilk AL, Kelsey FO. Teratogen update: Vitamin A congeners. Teratology 33: 355–364, 1986

    PubMed  CAS  Google Scholar 

  • Rubin MG, Hanno R. Short term etretinate for pustular psoriasis. Journal of the American Academy of Dermatology 12: 896–897, 1985

    PubMed  CAS  Google Scholar 

  • Saurat JH, Merot Y. Etretinate therapy and palmoplantar lesions. Correspondence. Acta Dermato-Venereologica 66: 458, 1986

    Google Scholar 

  • Schill WB, Wagner A, Nikolowsky J, et al. Aromatic retinoid and 13-cis-retinoic acid: spermatological investigation. In Orfanos et al. (Eds) Retinoids: advances in basic research and therapy, pp. 389–399, Springer, Berlin, 1981

    Google Scholar 

  • Schleicher SM. Oral isotretinoin and inflammatory bowel disease. Journal of the American Academy of Dermatology 13: 834–835, 1985

    PubMed  CAS  Google Scholar 

  • Shalita AR, Cunningham WJ, Leyden JJ, et al. Isotretinoin treatment of acne and related disorders: an update. Journal of the American Academy of Dermatology 9: 629–638, 1983

    PubMed  CAS  Google Scholar 

  • Sillevis Smith JH, De Mari FE. A serious side effect of etretinate (Tigason). Clinical Experiments in Dermatology 9: 554–556, 1984

    Google Scholar 

  • Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of multicenter dose-response study. Journal of the American Academy of Dermatology 10: 490–496, 1984

    PubMed  CAS  Google Scholar 

  • Taieb A, Maleville J. Retinoid dermatitis mimicking ‘eczema craquele’. Acta Dermato-Venereologica 65: 570, 1985

    PubMed  CAS  Google Scholar 

  • Tamayo L, Ruiz-Maldonado R. Long term follow-up of 30 children under oral retinoid Ro 10-9359. In Orfanos et al. (Eds) Retinoids: advances in basic research and therapy, pp. 287–294, Springer, Berlin, 1981

    Google Scholar 

  • Torok L. Spermatological examinations in males treated with etretinate. In Cunliffe & Miller (Eds) Retinoid therapy, pp. 161–164, MTP Press, Lancaster, 1984

    Google Scholar 

  • Torok L, Kasa M. Spermatological and endocrinological examinations connected with isotretinoin treatment. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 407–441, Karger, Basel, 1985

    Google Scholar 

  • Vahlquist A, Loof L, Mordlinder H, et al. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmo plantar psoriasis. Acta Dermato-Venereologica 65: 359–362, 1982

    Google Scholar 

  • Vahlquist A, Michaelsson G, Kober A, Sjoholm I, Palmskog G, et al. Retinoid binding proteins and the plasma transport of etretinate (RO 10-9359) in man. In Orfanos et al. (Eds) Retinoids: advances in basic research and therapy, pp. 109–116, Springer, Berlin, 1981

    Google Scholar 

  • Vahlquist C, Michaelsson G, Vahlquist A, et al. A sequential comparison of etretinate and isotretinoin with special regard to their effects on serum lipoproteins. British Journal of Dermatology 112: 69–76, 1985

    PubMed  CAS  Google Scholar 

  • Van der Rhee HJ. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double blind trial. British Journal of Dermatology 102: 203–212, 1980

    PubMed  Google Scholar 

  • Van Voorst Vader PC, Houthoff HJ, Eggink HF, et al. Etretinate (Tigason) hepatitis in 2 patients. Dermatologica 168: 41–46, 1984

    PubMed  Google Scholar 

  • Van Voorst Vader PC, Houthoff HJ, Gips CH, et al. Hepatologic side effects during long-term retinoid therapy: to cells and portal hypertension. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 498–500, Karger, Basel, 1985

    Google Scholar 

  • Viraben R, Mathien C, Fontan B. Benign intracranial hypertension during etretinate therapy for mycosis fungoides. Journal of the American Academy of Dermatology 13: 515–517, 1985

    PubMed  CAS  Google Scholar 

  • Voorhees CV. Retinoic acid embryopathy. Correspondence. New England Journal of Medicine 315: 262–263, 1986

    Google Scholar 

  • Weiss VC, West DD, Ackerman R, et al. Hepatotoxic reactions in a patient treated with etretinate. Archives of Dermatology 120: 104–106, 1984

    PubMed  CAS  Google Scholar 

  • Weiss VC, Layden T, Spinowitzs, et al. Chronic active hepatitis associated with etretinate therapy. British Journal of Dermatology 112: 591–597, 1985

    PubMed  CAS  Google Scholar 

  • Weleber RG, Denman ST, Hanifin JM, et al. Abnormal retinal function associated with isotretinoin therapy for acne. Archives of Ophthalmology 104: 831–837, 1986

    PubMed  CAS  Google Scholar 

  • Windhorst DB, Nigra T. General clinical toxicology of oral retinoids. Journal of the American Academy of Dermatology 6: 675–682, 1982

    PubMed  CAS  Google Scholar 

  • Woll PJ, Kostrezewski A, Glen Boat AM. Lymphoma in patients taking etretinate. Lancet 2: 563, 1987

    PubMed  CAS  Google Scholar 

  • Wong RC, Gilbert M, Yoo Ty, et al. Photosensitivity and isotretinoin therapy. Journal of the American Academy of Dermatology 14: 1095–1096, 1986

    PubMed  CAS  Google Scholar 

  • Zachariae H, Roged E, Bjerring P, et al. Liver biopsy during etretinate (Tigason) treatment. In Saurat (Ed.) Retinoids: new trends in research and therapy, pp. 494–497, Karger, Basel, 1985

    Google Scholar 

  • Zech LA, Gross EG, McClean SW, et al. Lipoprotein metabolism in patients receiving synthetic retinoids isotretinoin and etretinate. Arteriosclerosis I, 5,390A, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Beilinson Medical Center, Sackler Medical School, Tel Aviv University, Tel Aviv, Israel

    Michael David, Emmilia Hodak & Nicholas J. Lowe

  2. Division of Dermatology, UCLA School of Medicine, University of California, Los Angeles, California, USA

    Michael David, Emmilia Hodak & Nicholas J. Lowe

Authors
  1. Michael David
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmilia Hodak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicholas J. Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

David, M., Hodak, E. & Lowe, N.J. Adverse Effects of Retinoids. Dis-Manage-Health-Outcomes 3, 273–288 (1988). https://doi.org/10.1007/BF03259940

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259940

Keywords

Search

Navigation